Annual General Meeting 2014
The shareholders approved the annual report, the financial statements and the consolidated financial statements for 2013 and agreed to a dividend of CHF 3,85 per share as well an extraordinary dividend of 2,00 CHF per share. Payout is scheduled for May 13, 2014.
Additionally, the Annual General Meeting granted discharge to the Board of Directors and the Management Board for the 2013 business year.
Board of Directors
Dr. Renato Fassbind, Juergen Fitschen, Karl Gernandt, Klaus-Michael Kuehne, Hans Lerch, Dr. Thomas Staehelin, Dr. Joerg Wolle and Bernd Wrede were re-elected to the Board of Directors for one-year terms.
Dr. Martin Wittig, a German citizen, was newly elected to the Board of Directors.
In line with the Ordinance against Excessive Compensation in Public Corporations, for the first time the shareholders voted directly for the Chairman of the Board of Directors, the members of the Nomination and Compensation Committee and the independent proxy.
Chairman of the Board of Directors
With a clear majority of votes Karl Gernandt has been re-elected as Chairman of the Board of Directors for another one-year term.
Nomination and Compensation Committee
The shareholders followed the Board of Directors’ recommendation to elect
Karl Gernandt, Klaus-Michael Kuehne, Hans Lerch, Dr. Joerg Wolle and Bernd Wrede to the Nomination and Compensation Committee for a one-year term.
Independent Proxy/ Statutory Auditor
Kurt Gubler, Investarit AG, Zurich has been confirmed as independent proxy; the mandate as Statutory Auditor for the year 2014 has been given to Ernst & Young AG, Zurich.
Continuation of authorised share capital
The General Assembly approved the continuation of the authorised
share capital until 2016 including the respective change of the Articles of Associations.
The next Annual General Meeting will be held on May 5, 2015.